Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Alings

Showing results (91-100 of 127) with videos related to

Pageof 13
Sort By:
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 31, 2025
Cost-effectiveness of Apixaban vs Aspirin for the Reduction of Thrombo-Embolism in High-Risk Patients with Device-Detected Atrial Fibrillation: Insights from the ARTESiA trialAndre Lamy, Roopinder K Sandhu, Wesley Tong, et al.
The Lancet. Neurology|January 25, 2025
Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trialAshkan Shoamanesh, Thalia S Field, Shelagh B Coutts, et al.
Journal of the American College of Cardiology|November 15, 2018
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES TrialMichael Szarek, Harvey D White, Gregory G Schwartz, et al.
CJC Open|November 29, 2022
INTERBLEED: Design of an International Study of Risk Factors for Gastrointestinal Bleeding and Cardiovascular Events After Gastrointestinal BleedingJacqueline Bosch, Paul Moayyedi, Marco Alings, et al.
BMJ Open|May 30, 2025
Global research initiative for patient screening on MASH (GRIPonMASH) protocol: rationale and design of a prospective multicentre studyVivian D de Jong, Marco Alings, Radan Bruha, et al.
European Journal of Heart Failure|March 13, 2026
Heart failure patients with reduced or mildly reduced ejection fraction: baseline characteristics of the low-dose digoxin outcome DECISION trialPeter van der Meer, Geert H D Voordes, Marlene A T Vijver, et al.
European Journal of Preventive Cardiology|May 14, 2025
Risk factors associated with Gastrointestinal Bleeding in Patients with Cardiovascular Disease (INTERBLEED): a case control studyJacqueline Bosch, Martin O'Donnell, Qilong Yi, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 15, 2023
The genetic basis of apparently idiopathic ventricular fibrillation: a retrospective overviewLisa M Verheul, Martijn H van der Ree, Sanne A Groeneveld, et al.
Clinical Cardiology|October 24, 2023
Cardioversion strategy impacts rate control during recurrences in patients with paroxysmal atrial fibrillation: A subanalysis of the RACE 7 ACWAS trialRachel M J van der Velden, Nikki A H A Pluymaekers, Elton A M P Dudink, et al.
The New England Journal of Medicine|March 19, 2019
Early or Delayed Cardioversion in Recent-Onset Atrial FibrillationNikki A H A Pluymaekers, Elton A M P Dudink, Justin G L M Luermans, et al.
Pageof 13

Showing results (91-100 of 127) with videos related to

Sort By:
Pageof 13
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 31, 2025
Cost-effectiveness of Apixaban vs Aspirin for the Reduction of Thrombo-Embolism in High-Risk Patients with Device-Detected Atrial Fibrillation: Insights from the ARTESiA trialAndre Lamy, Roopinder K Sandhu, Wesley Tong, et al.
The Lancet. Neurology|January 25, 2025
Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trialAshkan Shoamanesh, Thalia S Field, Shelagh B Coutts, et al.
Journal of the American College of Cardiology|November 15, 2018
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES TrialMichael Szarek, Harvey D White, Gregory G Schwartz, et al.
CJC Open|November 29, 2022
INTERBLEED: Design of an International Study of Risk Factors for Gastrointestinal Bleeding and Cardiovascular Events After Gastrointestinal BleedingJacqueline Bosch, Paul Moayyedi, Marco Alings, et al.
BMJ Open|May 30, 2025
Global research initiative for patient screening on MASH (GRIPonMASH) protocol: rationale and design of a prospective multicentre studyVivian D de Jong, Marco Alings, Radan Bruha, et al.
European Journal of Heart Failure|March 13, 2026
Heart failure patients with reduced or mildly reduced ejection fraction: baseline characteristics of the low-dose digoxin outcome DECISION trialPeter van der Meer, Geert H D Voordes, Marlene A T Vijver, et al.
European Journal of Preventive Cardiology|May 14, 2025
Risk factors associated with Gastrointestinal Bleeding in Patients with Cardiovascular Disease (INTERBLEED): a case control studyJacqueline Bosch, Martin O'Donnell, Qilong Yi, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 15, 2023
The genetic basis of apparently idiopathic ventricular fibrillation: a retrospective overviewLisa M Verheul, Martijn H van der Ree, Sanne A Groeneveld, et al.
Clinical Cardiology|October 24, 2023
Cardioversion strategy impacts rate control during recurrences in patients with paroxysmal atrial fibrillation: A subanalysis of the RACE 7 ACWAS trialRachel M J van der Velden, Nikki A H A Pluymaekers, Elton A M P Dudink, et al.
The New England Journal of Medicine|March 19, 2019
Early or Delayed Cardioversion in Recent-Onset Atrial FibrillationNikki A H A Pluymaekers, Elton A M P Dudink, Justin G L M Luermans, et al.
Pageof 13